世界のパーキンソン病治療薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Parkinsons Disease Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、パーキンソン病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。パーキンソン病治療薬の種類別市場規模(臨床、実験)、用途別市場規模(治療、予防)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:臨床、実験
・用途別分析2016年-2026年:治療、予防
・パーキンソン病治療薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・パーキンソン病治療薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・パーキンソン病治療薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・パーキンソン病治療薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・パーキンソン病治療薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Parkinsons Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Parkinsons Disease Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Parkinsons Disease Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Parkinsons Disease Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Clinical
Experiment

Market segment by Application can be divided into
Treament
Prevention

The key market players for global Parkinsons Disease Drugs market are listed below:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Parkinsons Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Parkinsons Disease Drugs, with price, sales, revenue and global market share of Parkinsons Disease Drugs from 2019 to 2021.
Chapter 3, the Parkinsons Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinsons Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Parkinsons Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Parkinsons Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Parkinsons Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinsons Disease Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Clinical
1.2.3 Experiment
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinsons Disease Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Treament
1.3.3 Prevention
1.4 Global Parkinsons Disease Drugs Market Size & Forecast
1.4.1 Global Parkinsons Disease Drugs Sales in Value (2016-2026))
1.4.2 Global Parkinsons Disease Drugs Sales in Volume (2016-2026)
1.4.3 Global Parkinsons Disease Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Parkinsons Disease Drugs Production Capacity Analysis
1.5.1 Global Parkinsons Disease Drugs Total Production Capacity (2016-2026)
1.5.2 Global Parkinsons Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Parkinsons Disease Drugs Market Drivers
1.6.2 Parkinsons Disease Drugs Market Restraints
1.6.3 Parkinsons Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Parkinsons Disease Drugs Product and Services
2.1.4 Johnson & Johnson Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Parkinsons Disease Drugs Product and Services
2.2.4 Gilead Sciences Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pacira
2.3.1 Pacira Details
2.3.2 Pacira Major Business
2.3.3 Pacira Parkinsons Disease Drugs Product and Services
2.3.4 Pacira Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Product and Services
2.4.4 Sun Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Luye Pharma
2.5.1 Luye Pharma Details
2.5.2 Luye Pharma Major Business
2.5.3 Luye Pharma Parkinsons Disease Drugs Product and Services
2.5.4 Luye Pharma Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sigma-Tau Group
2.6.1 Sigma-Tau Group Details
2.6.2 Sigma-Tau Group Major Business
2.6.3 Sigma-Tau Group Parkinsons Disease Drugs Product and Services
2.6.4 Sigma-Tau Group Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Fudan-Zhangjiang
2.7.1 Fudan-Zhangjiang Details
2.7.2 Fudan-Zhangjiang Major Business
2.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Product and Services
2.7.4 Fudan-Zhangjiang Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Product and Services
2.8.4 Teva Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 CSPC
2.9.1 CSPC Details
2.9.2 CSPC Major Business
2.9.3 CSPC Parkinsons Disease Drugs Product and Services
2.9.4 CSPC Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Parkinsons Disease Drugs Product and Services
2.10.4 Novartis Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Kingond Pharm
2.11.1 Kingond Pharm Details
2.11.2 Kingond Pharm Major Business
2.11.3 Kingond Pharm Parkinsons Disease Drugs Product and Services
2.11.4 Kingond Pharm Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Parkinsons Disease Drugs Sales by Manufacturer
3.1 Global Parkinsons Disease Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Parkinsons Disease Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Parkinsons Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Parkinsons Disease Drugs Manufacturer Market Share
3.4.2 Top 6 Parkinsons Disease Drugs Manufacturer Market Share
3.5 Global Parkinsons Disease Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Parkinsons Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Parkinsons Disease Drugs Market Size by Region
4.1.1 Global Parkinsons Disease Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Parkinsons Disease Drugs Revenue by Region (2016-2026)
4.2 North America Parkinsons Disease Drugs Revenue (2016-2026)
4.3 Europe Parkinsons Disease Drugs Revenue (2016-2026)
4.4 Asia-Pacific Parkinsons Disease Drugs Revenue (2016-2026)
4.5 South America Parkinsons Disease Drugs Revenue (2016-2026)
4.6 Middle East and Africa Parkinsons Disease Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Parkinsons Disease Drugs Sales in Volume by Type (2016-2026)
5.2 Global Parkinsons Disease Drugs Revenue by Type (2016-2026)
5.3 Global Parkinsons Disease Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Parkinsons Disease Drugs Sales in Volume by Application (2016-2026)
6.2 Global Parkinsons Disease Drugs Revenue by Application (2016-2026)
6.3 Global Parkinsons Disease Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Parkinsons Disease Drugs Sales by Type (2016-2026)
7.2 North America Parkinsons Disease Drugs Sales by Application (2016-2026)
7.3 North America Parkinsons Disease Drugs Market Size by Country
7.3.1 North America Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Parkinsons Disease Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Parkinsons Disease Drugs Sales by Type (2016-2026)
8.2 Europe Parkinsons Disease Drugs Sales by Application (2016-2026)
8.3 Europe Parkinsons Disease Drugs Market Size by Country
8.3.1 Europe Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Parkinsons Disease Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Parkinsons Disease Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Parkinsons Disease Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Parkinsons Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Parkinsons Disease Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Parkinsons Disease Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Parkinsons Disease Drugs Sales by Type (2016-2026)
10.2 South America Parkinsons Disease Drugs Sales by Application (2016-2026)
10.3 South America Parkinsons Disease Drugs Market Size by Country
10.3.1 South America Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Parkinsons Disease Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Parkinsons Disease Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Parkinsons Disease Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Parkinsons Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Parkinsons Disease Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Parkinsons Disease Drugs Typical Distributors
12.3 Parkinsons Disease Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

...

【掲載企業】

Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のパーキンソン病治療薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Parkinsons Disease Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。